NCT02987738View on ClinicalTrials.gov

Pilot Study to Explore the Efficacy of DAPAglifozin as add-on to Closed-loop Control in Patients With Type 1 Diabetes

PHASE1CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

February 9, 2017

Primary Completion Date

December 19, 2017

Study Completion Date

December 19, 2017

Conditions

Type1diabetes

Interventions

DRUG

Dapagliflozin

two administrations in the evening and 12 hours later

DRUG

Placebo Oral Tablet

two administrations in the evening and 12 hours later

Trial Locations (1)

30173

Kinder - und Jugendkrankenhaus AUF DER BULT, Hanover

Sponsors

Collaborators (2)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

collaborator

Alcedis GmbH

INDUSTRY

lead

Kinderkrankenhaus auf der Bult

OTHER